These data were also parallel to the degree of decreased hyperlipidemia and hepatic steatosis and improved liver function indices ALT and AST, suggesting that the AMPK/ACC/SREBP‐1c pathway likely participates in mediating the anti‐obesity and metabolic disorder improvement properties of alisol A. The gene discussed is GPT; the disease is obesity due to melanocortin 4 receptor deficiency.